Medical specialists from France tagged as investigators in clinical trials studying Neuroendocrine Tumor
Total 37 results
-
A Principal Investigator Designated by the Sponsor, M.D.Seen in:
- Bourdeaux, Centre Hospitalier Universitaire (CHU) Bordeux
- Lille, Lille University Hospital
- Lyon, Hôpital Edouard Herriot, Lyon
- Marseille, Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, France
- Montpellier, Department of Digestive Oncology, CHU Saint Eloi, Montpellier, France/ ICM Cancer Institute at Montpellier
- Nantes, Centre Hospitalier Universitaire de Nantes
- Paris, I. Gustave Roussy, Paris
- Toulouse, Department of Digestive Oncology - IUCT Rangueil-Larrey, CHU de Toulouse, Toulouse, France
Trials:- NCT05918302 (Principal Investigator)
-
Amandine BeronSeen in:
- Lille, CHRU de Lile
Trials:- NCT05477576 (Principal Investigator)
-
Antoine ITALIANO, MD, PhDSeen in:
- Bordeaux, Institut Bergonie
Trials:- NCT03475953 (Sub-Investigator)
Conditions:- Hepatocellular Carcinoma;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Soft-tissue Sarcoma;
- Urothelial Carcinoma;
- Thyroid Cancer;
- Gastro-enteropancreatic Neuroendocrine Tumor;
- Biliary Tract Cancer;
- HPV-Related Carcinoma;
- Solid Tumor, Adult;
- Mesotheliomas Pleural;
- GIST;
- Renal Carcinoma;
- Colorectal Cancer Not MSI-H or MMR-deficient;
- Oesophageal or Gastric Carcinoma
-
Bachar EL-SAYADISeen in:
- Évreux, CH Eure Seine - Hopital d'Evreux Vernon
Trials:- NCT05443087 (Principal Investigator)
-
Bernard WilleminSeen in:
- Strasbourg, Service d'Hématologie et d'Oncologie
Trials:- NCT04134832 (Sub-Investigator)
Conditions: -
Catherine AnsquerSeen in:
- Cedex, Nantes, Nantes University Hospital Center - Hotel Dieu Hospital
- Nantes, CHU de Nantes
- Nantes, Médecine nucléaire - CHU Nantes
Trials:- NCT04919226 (Principal Investigator)
- NCT05477576 (Principal Investigator)
- NCT06256705 (Principal Investigator)
-
David MALKASeen in:
- Paris, Institut Mutualiste de Montsouris
Trials:- NCT05443087 (Principal Investigator)
-
David TAIEB, MDSeen in:
- Marseille, Assistance Publique Hopitaux de Marseille
Trials:- NCT02150408 (Principal Investigator)
Conditions: -
Denis SmithSeen in:
- Other, Pessac, CHU Bordeaux Hopital Haut-Leveque
- Pessac cedex, GSK Investigational Site
- Pessac, CHU - Haut Lévêque
- Pessac, CHU Bordeaux
- Pessac, Chu - Hôpital Haut Lévêque
- Talence, CHU de Bordeaux
Trials:- NCT05254639 (Principal Investigator)
- NCT04579679 (Principal Investigator)
- NCT04262687 (Principal Investigator)
- NCT02885753 (Principal Investigator)
- NCT05253651 (Principal Investigator)
- NCT05723562 (Principal Investigator)
- NCT05855200 (Principal Investigator)
-
Elodie ChevalierSeen in:
- Vandoeuvre-Lès-Nancy, CHRU de Nancy Hôpital de Brabois
Trials:- NCT05477576 (Principal Investigator)
-
Emmanuel AchilleSeen in:
- Strasbourg, Service d'Hématologie et d'Oncologie
Trials:- NCT04134832 (Sub-Investigator)
Conditions: -
Eric Baudin, MDSeen in:
- Villejuif, Institut Gustave Roussy
Trials:- NCT04187404 (Principal Investigator)
- NCT05477576 (Principal Investigator)
-
François GERNIERSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT05500391 (Principal Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Gabriel MALOUF, MD, PhDSeen in:
- Strasbourg, Service d'Hématologie et d'Oncologie
- Strasbourg, Service d'Oncologie - CHU de Strasbourg - France
Trials:- NCT04089306 (Principal Investigator)
- NCT05617105 (Principal Investigator)
- NCT04134832 (Principal Investigator)
- NCT05234450 (Principal Investigator)
-
Ghoufrane TLILISeen in:
- Pessac, CHU Bordeaux - Hôpital Haut Lévêque
Trials:- NCT04837885 (Principal Investigator)
-
Guillaume BONNETSeen in:
- Amiens, CHU Amiens
Trials:- NCT05500391 (Principal Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Jean-Marc Limacher, MDSeen in:
- Strasbourg, Service d'Hématologie et d'Oncologie
Trials:- NCT04134832 (Sub-Investigator)
Conditions: -
Julien HadouxSeen in:
- Villejuif Cedex, Gustave Roussy
- Villejuif, Institut Gustave Roussy
Trials:- NCT04579679 (Principal Investigator)
- NCT04211337 (Principal Investigator)
-
Laurence ROTSAERTSeen in:
- Lille, Centre OSCAR LAMBRET
Trials:- NCT05500391 (Principal Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
LEBTAHI Rachida, PrSeen in:
- Clichy, Médecine nucléaire et Biophysique - Beaujon
Trials:- NCT06256705 (Principal Investigator)
Conditions: -
Louis de MestierSeen in:
- Clichy, CHU Beaujon, APHP.Nord - Université Paris Cité
- Clichy, Pancréatologie et Oncologie Digestive - Beaujon
Trials:- NCT05477576 (Principal Investigator)
- NCT06256705 (Principal Investigator)
-
Louis-Marie DourtheSeen in:
- Strasbourg, Service d'Hématologie et d'Oncologie
Trials:- NCT04134832 (Sub-Investigator)
Conditions: -
Mathieu BOONE, MDSeen in:
- Amiens, CHU Amiens
Trials:- NCT05500391 (Sub-Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Meher Ben AbdelghaniSeen in:
- Strasbourg, Service d'Hématologie et d'Oncologie
Trials:- NCT04134832 (Sub-Investigator)
Conditions: -
Nicolas PENEL, MDSeen in:
- Lille, Centre OSCAR LAMBRET
Trials:- NCT05500391 (Sub-Investigator)
Conditions:- Glioma;
- Gastrointestinal Stromal Tumors;
- Neuroendocrine Tumors;
- Adenocarcinoma, Clear Cell;
- Carcinoma, Small Cell;
- Ovarian Germ Cell Tumor;
- Stage I Testicular Seminoma;
- Stage I Testicular Nonseminomatous Germ Cell Tumor;
- Borderline Ovarian Tumor;
- Sex Cord-Stromal Tumor;
- Mucinous Adenocarcinoma of Ovary;
- Carcinosarcoma, Ovarian;
- Serous Tumor of Ovary;
- Aggressive Fibromatosis of Abdominal Wall (Disorder)
-
Pietro ADDEO, MDSeen in:
- Strasbourg, Service de Chirurgie Générale, Hépatique, Endocrinienne et Transplantation - CHU de Strasbourg - France
Trials:- NCT05528614 (Principal Investigator)
Conditions: -
Romain CHAUTARDSeen in:
- Tours, CHU de Tours
Trials:- NCT05443087 (Principal Investigator)
-
Sophie Cousin, MDSeen in:
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, EDOG - Institut Bergonie - PPDS
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05403385 (Principal Investigator)
- NCT04880382 (Principal Investigator)
- NCT03475953 (Principal Investigator)
- NCT05668585 (Principal Investigator)
- NCT05027867 (Principal Investigator)
Conditions:- Metastatic NSCLC;
- Stage III NSCLC;
- Non Small Cell Lung Cancer;
- Hepatocellular Carcinoma;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Soft-tissue Sarcoma;
- Urothelial Carcinoma;
- Thyroid Cancer;
- Gastro-enteropancreatic Neuroendocrine Tumor;
- Biliary Tract Cancer;
- HPV-Related Carcinoma;
- Solid Tumor, Adult;
- Mesotheliomas Pleural;
- GIST;
- Renal Carcinoma;
- Colorectal Cancer Not MSI-H or MMR-deficient;
- Oesophageal or Gastric Carcinoma;
- Melanoma;
- NSCLC;
- Solid Tumors;
- CRC;
- ATC;
- Small Cell Lung Carcinoma;
- Small-cell Lung Cancer;
- Small Cell Lung Cancer Extensive Stage;
- Small Cell Lung Cancer Recurrent
Clinical Trials on Neuroendocrine Tumor
-
National Cancer Institute (NCI)RecruitingLocally Advanced Lung Neuroendocrine Neoplasm | Lung Neuroendocrine Neoplasm | Metastatic Lung Neuroendocrine Neoplasm | Recurrent Lung Neuroendocrine Neoplasm | Unresectable Lung Neuroendocrine Neoplasm | Advanced Lung Neuroendocrine Tumor | Functioning Lung Neuroendocrine Tumor | Lung Neuroendocrine... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Functioning Pancreatic Neuroendocrine Tumor | Intermediate Grade Lung Neuroendocrine Neoplasm | Locally Advanced Pancreatic Neuroendocrine Tumor | Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm | Low Grade Lung Neuroendocrine Neoplasm | Metastatic Digestive... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Digestive System Neuroendocrine Tumor G1 | Metastatic Carcinoid Tumor | Recurrent Digestive System Neuroendocrine Tumor G1 | Regional Digestive System Neuroendocrine Tumor G1 | Midgut Neuroendocrine Tumor G1 | Foregut Neuroendocrine Tumor | Hindgut Neuroendocrine Tumor | Neuroendocrine...Canada, United States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Dana-Farber Cancer InstituteBayer; NovartisCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
University of WashingtonEli Lilly and CompanyRecruitingLocally Advanced Unresectable Digestive System Neuroendocrine Neoplasm | Metastatic Digestive System Neuroendocrine Neoplasm | Pancreatic Neuroendocrine Tumor | Advanced Digestive System Neuroendocrine Neoplasm | Digestive System Neuroendocrine Tumor | Foregut Neuroendocrine Tumor | Hindgut Neuroendocrine... and other conditionsUnited States
-
University of Roma La SapienzaRecruitingNeuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Neoplasm | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1Italy
-
TaiRx, Inc.Active, not recruitingNeuroendocrine Tumors | Gastro-enteropancreatic Neuroendocrine Tumor | Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor | Lung Neuroendocrine NeoplasmTaiwan